baber/WOPTO huggingface dataset:
Patent JP-H10500635-A (JP)
IPC: B32B27/28
Filed: 1995-05-16
Abstract: PCT No. PCT/FI95/00255 Sec. 371 Date Feb. 24, 1997 Sec. 102(e) Date Feb. 24, 1997 PCT Filed May 16, 1995 PCT Pub. No. WO95/32094 PCT Pub. Date Nov. 30, 1995The invention relates to a multilayer product for the production of packaging, the product comprising a carrier web (1), on one face of which there is disposed a tight multilayer coating (2) which includes a moisture-proof layer (b) and a gas-tight layer (a). The gas-tight layer is made up of a blend of an ethylene/vinyl alcohol copolymer and a polar ethylene polymer. The moisture-proof layer is polyolefin, preferably a blend of polyethylene and a polar ethylene polymer.
Patent JP-2001509338-A (JP)
Title: 無線機器用アンテナ
IPC: H01Q1/27
Filed: 1997-01-29
Abstract: (57)【要約】
本発明の無線機器用アンテナ１２は、移動通信の無線電話機およびＰＣＳ等の無線機器に設置され、所定の電波をより効率的に送信し受信するものである。このアンテナ１２は、一つの終端に円形の溝部１０を有する一体型の支持部１１を備えているとともに、アンテナ１２の下端の終端部分に、円形の挿入部１３および長孔１４を有する連結片１５を備えており、前記連結片１５の挿入部１３が、支持部１１の溝部１０に、弾性的に、かつ、分離可能に挿入されている。これにより、アンテナの構造を簡単なものとできるとともに、製造コストを節減できる。さらに、アンテナ１２の位置を必要に応じて調整できるという効果がある。
Patent JP-2001520752-A (JP)
IPC: G01N30/02
Filed: 1999-01-28
Abstract: A method of generating a base comprising the steps of: 
(a) providing a cation source in a cation source reservoir (10), 
(b) flowing an aqueous liquid stream through a first base generation chamber (19) separated from said cation source reservoir by a first barrier (14) substantially preventing liquid flow while providing a cation transport bridge, 
(c) applying an electric potential between an anode (16) in electrical communication with said cation source reservoir and a cathode (18) in electrical communication with said first base generation chamber to electrolytically generate hydroxide ions in said first base generation chamber and to cause cations in said cation source reservoir to electromigrate toward said first barrier and to be transported across said first barrier toward said cathode to combine with said hydroxide ions generated at the cathode to form cation hydroxide, and 
(d) removing the cation hydroxide in an aqueous liquid stream (21) as an effluent from said first base generation chamber.
Patent JP-2001522280-A (JP)
Title: 滅菌コネクタ
IPC: A61J1/05
Filed: 1998-04-24
Abstract: (57)【要約】
薬用液を収容した容器にチューブ管路を接続するための滅菌コネクタが接続部材（２）を有し、この接続部材が通路状凹部（１７）を備えており、穿通可能な膜によってこの凹部が閉鎖されている。穿通可能な膜は接続部材の通路状凹部を覆うフィルム（１８）として構成されており、このフィルムはバッグフィルムに溶融接合可能な接続部材の下面に溶融接合されている。折取り部品として構成される保護キャップ（５）が接続部材の通路状凹部を閉鎖する。このコネクタは容器内容物の細菌汚染に対し高い安全性を提供し、容易に取り扱うことができ、大量個数安価に製造することができる。
Patent MX-158401-A (MX)
Inventor: ALBERT FRANK JR
IPC: F16D3/20
Filed: 1982-05-19
Abstract: A ball type universal joint construction where a ball member is rotatably received in a housing and a bearing structure interposed therebetween in a manner which limits the relative rotational degrees of freedom. The ball member has a spherical surface portion which includes axially extending bearing receiving slots and the housing has a cavity spherical surface portion which includes bearing receiving recesses in registry with the receiving slots. Ball type bearings disposed partially within the recesses and partially within the slots limit movement between the ball member and housing to articulated movement relative to each other. The housing also includes an access opening at one end face having an enlargement through which the ball member can be passed when rotated 90 degrees to its nominal, functioning position. This allows the ball member to be inserted into the housing through the enlargement while at the same time accommodating passage of the bearings into the housing recesses. Thereafter, the ball member is further rotated such that the receiving slots also partially receive the bearings and thus capture the ball member in an articulating, non-rotatable relationship in the housing.
Patent NZ-190914-A (NZ)
Title: Hemi-esters of steryl glycoscides and pharmaceutical compositions
Inventor: ROGERS C B
IPC: A61K31/58
Filed: 1979-07-04
Abstract: The invention is concerned with new chemical compounds being the hemiesters of steryl glycosides, methods of preparing these hemiesters, and pharmaceutically, particularly anti-inflammatory, compositions containing the new hemiesters.
Patent NZ-194192-A (NZ)
Title: Long-acting injectable composition containing sulfadimethoxine or sulfamethazine
Inventor: ARMSTRONG W
IPC: A61K31/63
Filed: 1980-06-30
Abstract: A long acting liquid sulfonamide injectable composition comprising (a) water (b) from 5 to 25% w/v based on the total volume of the solution of a sulfonamide selected from sulfadimethoxine and sulfamethazine and (c) 40 to 65% w/v based on the total volume of the solution of a co-solvent selected from 2-pyrrolidone and N-methylpyrrolidone, the composition having a pH of from 5 to 9.5. The compositions may also include from 1 to 5% w/v based on the total volume of solution of polyvinylpyrrolidone having an m.w. of 5000-100,000.
Patent NZ-226460-A (NZ)
Title: Aromatic compounds containing essentially either a pyridyl or a pyrimidinyl substituent; pharmaceutical compositions and preparatory processes
Inventor: EARL RICHARD ALAN
IPC: C07D213/32
Filed: 1988-10-04
Abstract: Cognitive defeciencies or neurological dysfunction in mammals are treated with  alpha , alpha -disubstituted aromatic or heteroaromatic compounds. The compounds have the formula: <CHEM>  or a salt thereof wherein X and Y are taken together to form a saturated or unsaturated carbocyclic or heterocyclic first ring and the shown carbon in said ring is  alpha  to at least one additional aromatic ring or heteroaromatic ring fused to the first ring; one of Het<1> or Het<2> is 2, 3, or 4-pyridyl or 2, 4, or 5-pyrimidinyl and the other is selected from     (a) 2, 3, or 4-pyridyl,   (b) 2, 4, or 5-pyrimidinyl,   (c) 2-pyrazinyl,   (d) 3, or 4-pyridazinyl,   (e) 3, or 4-pyrazolyl,   (f) 2, or 3-tetrahydrofuranyl, and (g) 3-thienyl. i
Patent NZ-231411-A (NZ)
Title: Blister package for pliers with a compartment allowing partial operation prior to purchase
Inventor: THEROS BRIAN S
IPC: B65D75/36
Filed: 1989-11-16
Abstract: A working clamshell blister package (10) for a pliers (12) or similar tool includes a pair of opposing mirror-image panels (32,34) having recesses and joined along a common lower end to form a base portion (44). The base portion (44) is provided with a pair of openings (48) for accommodating the handles of the pliers (12) and has a bridge formation (50) located between the openings (48). When the opposing panels (32,34) are placed in contacting relation, a compartment is formed in which the working portion of the pliers (12) may be enclosed, with the junction of the pliers members being supported by the bridge formation (50). A pair of pliers (12) contained in the package may be manipulated a specified extent by the customer prior to purchase without opening the package (10).
Patent NZ-232824-A (NZ)
Title: Reaction products of mono- or bis-alkenyl succinimides and certain amino acids; use as a detergent in diesel fuel
Inventor: ASHJIAN HENRY
IPC: C10L1/22
Filed: 1990-03-07
Abstract: This invention relates to alkenyl succinimide reaction products; more particularly, this invention relates to reaction products of alkenyl mono- or bis-succinimides with ethylenediamine carboxylic acids; to their preparation and to their use in diesel fuel formulations as detergents.
Patent NZ-235625-A (NZ)
Title: Thixotropic binder system for coating composition
Inventor: NICKS PETER FRANCIS
IPC: C08G18/32
Filed: 1990-10-10
Abstract: A film-forming thixotropic binder system for imparting sag resistance to coating compositions comprising the product obtained by reacting an isocyanate preferably having a molecular weight of at least 400 and comprising more than two isocyanate groups (preferably an isocyanurate trimer obtained from di-isocyanates) with a polyamine and optionally a monoamine in the presence of a film-forming carboxylic acid copolymer having an acid value of at least 25 mg KOH/g copolymer. The binder composition may be neutralised by alkali to produce a salt soluble in an aqueous coating composition. Also detailed processes for making the binder system.
Patent NZ-260811-A (NZ)
Title: Recognition of speech by neural network affected by stress-induced variations in pronunciation
Inventor: TROMPF MICHAEL
IPC: G10L15/16
Filed: 1994-06-22
Abstract: Speech recognition of stress-afflicted speech with a high recognition rate. Use of a neural network (NN), utilising the non-linear imaging properties. In a training phase, systematic parameter changes of stress-afflicted speech are used to train a neural network. In a speech recognition phase, by means of the parameter change trained, an imaging of stress-afflicted speech patterns onto stress-free patterns is carried out. <IMAGE>
Patent NZ-299101-A (NZ)
Title: Computer-based document development system: includes text editor and language editor enforcing lexical and grammatical constraints
Inventor: CARBONELL JAIME GUILLERMO
IPC: G06F17/27
Filed: 1993-08-23
Abstract: The present invention is a system of integrated, computer-based processes for monolingual information development. and multilingual translation. An interactive text editor enforces lexical and grammatical constraints on a natural language subset used by the authors to create their text, which they help disambiguate to ensure translatability. The resulting translatable source language text undergoes machine translation into any one of a set of target languages, without the translated text requiring any postediting.
Patent NZ-320289-A (NZ)
Title: Pharmaceutical compositions of levo-enantiomers of medetomidine derivatives and their use
Inventor: AKERMAN KARL E
IPC: A61P43/00
Filed: 1996-10-23
Abstract: PCT No. PCT/FI96/00560 Sec. 371 Date Sep. 16, 1998 Sec. 102(e) Date Sep. 16, 1998 PCT Filed Oct. 23, 1996 PCT Pub. No. WO97/15302 PCT Pub. Date May 1, 1997The levo-isomers of certain imidazole derivatives, particularly medetomidine, have been found to be inverse agonists of adrenergic  alpha -2 receptors and are therefore useful in the prevention or treatment of conditions associated with overexpression or hypersensitization of the adrenergic  alpha -2 receptors, such as obesity, a withdrawal symptom to an adrenergic  alpha -2 receptor agonist, a neurological disorder, multiple system atrophy, diabetes mellitus, benign prostatic hyperplasia, and drug-induced sensitization of adrenergic  alpha -2 receptors. The pharmaceutical composition is preferably transdermal.
Patent NZ-335043-A (NZ)
Title: Communications system for monitoring the presence of animals in a natural feeding environment
Inventor: STEIN JOHN W
IPC: A01K11/00
Filed: 1997-09-12
Abstract: To detect the proximity of a tagged item such as a beast 1, the addresses of the tags 130 attached to the animals are transmitted on an unterminated conductive medium (wire) 110 from the system controller 100 and into the near field space adjacent to the conductive wire.  If a tag having one of the transmitted addresses is in proximity to the conductive wire when the address is sent, the tag will detect the sent address and respond to indicate that the cow is near to the wire.
Patent NZ-337285-A (NZ)
Title: Size adjustable in-line skate comprising a frame of two halves and a boot
Inventor: YANG LIEN-CHUAN
IPC: A63C17/00
Filed: 1999-08-18
Abstract: An in-line skate structure comprises a frame 10 and a boot 30 composed of a toe section 31, a heel section 36, a cuff section 42 and a latch section 50.  A bottom of the toe section is formed with a slide slot 34 (Fig. 2), a front end of the heel section is formed with a locating hole 37 and a rivet 60 is passed through hole 37 and slot 34 to loosely rivet with an insertion block 19 previously disposed in insertion cavities 11 at the front end of the frame.  A rear end of the heel section is formed with a locating hole 38 and a bolt 62 is passed through hole 38 to screw with a platform 12, 13 at the rear end of the frame.  The frame is composed of two halves A, B.  An adjustment thread rod 16 fitted in a spring 17 is passed through two sides of the frame near cavities 11, each cavity 11 being formed with an inner acute slope side and block 19 being formed with corresponding lateral slope sides.  When rotating and tightening rod 16, block 19 is sunk relative to the upper end of the frame and at the same time the toe section is pulled down so as to tightly associate the frame with the boot.  When untightening rod 16 the restoring force of the spring fitted therearound helps in separating the frame halves and in making block 19 move upward relative to the upper end of the frame so as to adjust the fixing position of the toe section and the heel section.
Patent NZ-503654-A (NZ)
Title: Generation of smooth pulse signal for powering of lamps and reduction of switching harmonics
Inventor: HAYASHI KOICHI
IPC: H03K17/16
Filed: 1998-10-08
Abstract: The electrical signal is generated in particular for use in controlling the illumination level of a lamp (10). The electrical signal (V4, 5) is generated as a hybrid combination of two voltage signal portions that are generated from two sinusoidal forms. The first sinusoidal form is the mains signal that could have a frequency at 50Hz or 60Hz (12). The second sinusoidal form is the result of an oscillating stage (16) that creates the sinusoidal form to have a much higher frequency than the mains frequency, such as 100kHz (V2). The first signal portion is generated following application of a biasing signal (V2) switching device such as a FET (14). The second signal portion is generated by application of a gating signal (V3) to a gating device such as a triac (11).
Patent NZ-508231-A (NZ)
Title: New compounds of 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo[3,4-c]carbazole and 12,13-(pyranosyl)-furo[3,4-c]indolo[2,3-a]carbazole a process for their preparation and pharmaceutical compositions containing them
Inventor: MOREAU PASCALE
IPC: C07H19/23
Filed: 2000-11-16
Abstract: Compounds of formula (I), more particularly, 12,13-(pyranosyl)-indol[2,3-a]pyrrolo[3,4-c]-carbazole and 12,13-(pyranosyl)-furo[3,4-c]indolo[2,3-a]carbazole and their use as anti-tumour agents in the treatment of cancers is disclosed.  Also described is the process for the manufacture of compounds of formula (I).
Patent NZ-512286-A (NZ)
Title: Cyclohexenone oxime ether (glyphosates / gluphosinates) suspension concentrates
Inventor: VON DER HEYDE JURGEN
IPC: A01N57/20
Filed: 1999-12-15
Abstract: An anhydrous formulation of plant-protectant active ingredients consisting of: a) a cyclohexenone oxime ether of formula (I) in which R1 is ethyl, propyl; R2 is hydrogen or an equivalent of an agriculturally useful cation; R3 is 2-(thioethyl)propyl, tetrahydrothiopyran-3-yl, tetrahydrothiopyran-4-yl, tetrahydropyran-3-yl, tetrahydropyran-4-yl, 1-(methylthio)cyclopropyl, 5-(isopropyl)-isoxazole-3-yl, 2,5-dimethylpyrazole-3-yl, 2,4,6-trimethylphenyl or 2,4,6-trimethyl-3-butyrylphenyl; R4, R5 are H, CH3, CO-OCH3; Alk is CH2CH2, CH2CH(CH3) CH2CH=CH, CH2CH=C(C1), CH2CH2CH=CH; R6 is H, phenyl, halogen phenyl, dihalogen phenyl, phenoxy, halogen phenoxy, dihalogen phenoxy; b) N-phosphonomethyl glycine, an ester or salt thereof, DL-homoalanine-4-yl (methyl)phospinic acid or the ammonium salt thereof; c) between 20 and 80 % by weight of an aprotic or weakly protic solvent in which the components a) and b) are suspended; d) possibly emulsifiers, tensides and surface-active and/or reinforcing additives.
Patent NZ-512661-A (NZ)
Title: Reovirus for the treatment of cellular proliferative disorders
Inventor: LEE PATRICK W K
IPC: A61K35/76
Filed: 2000-02-18
Abstract: A pharmaceutical composition for the treatment of ras-mediated proliferative disorder in a mammal is disclosed wherein it comprises a modified reovirus and a pharmaceutically acceptable excipient, wherein the reovirus is a recombinant or immunoprotected reovirus. This pharmaceutical composition is useful for treating either solid neoplasms or hematopoietic neoplasms.
Patent NZ-513490-A (NZ)
Title: Protective device against the effects of explosives
Inventor: PECHE JEAN PATRICK
IPC: F41H11/12
Filed: 2000-02-21
Abstract: A device for protecting the bottom part of human lower limbs, in particular the foot, against the propagation of the blast wave and the heat generated by the detonation of an explosive device such as a landmine. The device comprise an ankle boot whose sole has a dihedral under surface (1) with the summit formed by its two faces pointing downwards, surrounded by a series of supporting blocks (5) which provide stability and allow the wearer to proceed with a natural gait. The blocks are located under the anatomical supports of the foot - the big toe, the instep and heel. The sole is made from a non-rigid material with a Shore hardness of 40 - 80, with the supporting blocks made so that they do not form projectiles if they are shattered by an explosion.
Patent NZ-515586-A (NZ)
Title: Fibrin polymer structure
Inventor: HOLLINGSBEE DEREK A
IPC: A61L27/00
Filed: 2000-06-01
Abstract: In accordance with the present invention a novel fibrin polymer structure is disclosed. The novel fibrin polymer structure useful, for example, as a surgical sealant, is comprised of a plurality of discrete, droplets of polymerizing or polymerized fibrin each encapsulated by a "skin" of fibrin polymer. These fibrin-skin encapsulated droplets are applied so as to be built up one upon the other, layer by layer, to form an integral sealant structure. The cumulative effect of the encapsulating skins of those droplets which form the sealant surface is a surface skin which unexpectedly resists cell penetration but enhances cell migration across the surface. The sealant structure of the present invention can be prepared by spray delivery of fibrin polymer forming materials wherein the time required for the materials to commence polymerizing after mixing is less than or equal to the transit time of said materials from the applicator tip to the target surface.
Patent NZ-515750-A (NZ)
Title: Label dispensing head for plastic blow molding in-mould labelling system
Inventor: DUNLAP RICHARD L
IPC: B65C9/14
Filed: 2000-05-25
Abstract: A dispensing head (36) for an "in-mould" labelling system includes a lever assembly (106) rotationally driven by a rotary drive member (74) and having a pair of levers (108) that are adjustable with respect to the rotary drive member independently of each other. Each lever (108) has a cam and follower connection (112) to an associated label carrier (38) such that rotation of the rotary drive member (74) provides movement of the label carriers (38) between retracted and label transfer positions.
Patent NZ-516123-A (NZ)
Title: Improved canopy light
Inventor: HAUGAARD ERIC J
IPC: F21V17/10
Filed: 1998-06-08
Abstract: A canopy light for use at gasoline filling stations that uses a reflector in a housing that contains an easy to service ballast with all components of the light readily accessible from beneath, making it easy to re-lamp via a cover that is prevented from falling.
Patent NZ-518487-A (NZ)
Title: Immunogenic proteins from the domestic mite, blomia tropicalis
Inventor: CHUA KAW YAN
IPC: C12N15/12
Filed: 2000-10-10
Abstract: An isolated nucleic acid molecule or a functional derivative thereof comprising a nucleotide sequence encoding or complementary to a sequence encoding a protein allergen from a mite, preferably being Blomia tropicalis, or a derivative, homologue or mimetic of the allergen wherein the allergen is selected from Bt11, Bt10 and BtA2 and a polymorphic variant of Bt5; and the use of the nucleic acid molecule comprising a gene encoding Bt11 in the manufacture of a medicament for the prophylacsis or treatment of an allergic condition, such as allergic asthma, atopic dermatitis and/or rhinitis, in a subject.
Patent NZ-520467-A (NZ)
Title: Substituted aminomethyl-phenyl-cylohexane derivatives
Inventor: PUTZ CLAUDIA
IPC: A61K31/135
Filed: 2000-12-27
Abstract: The invention relates to substituted aminomethyl-phenyl- cyclohexane derivatives of formula (I) and formula (Ia), to methods for the production thereof, to their use for producing medicaments, and to medicaments containing these compounds for use in treating pain.
Patent NZ-521808-A (NZ)
Title: Synthetic process for the manufacture of an ecteinaschidin compound
Inventor: FRANCESCH ANDRES
IPC: C07D491/22
Filed: 2001-05-15
Abstract: A process step in the manufacture of an ecteinascidin compound comprising deprotecting a compound of formula (A) by removing both protecting groups in a single step to give an alpha aminolactone of formula (35), wherein ProtNH is an amino protecting group and ProtOH is a hydroxy protecting group. Further process steps include oxidizing the alpha aminolactone of formula (35) to a corresponding alpha ketolactone by transamination. Also disclosed are processes for forming the spirotetrahydroisoquinoline compounds Et770 and Et743
Patent NZ-529994-A (NZ)
Title: Device for connecting a functional unit which can be detachably arranged on a housing
Inventor: ATTINGER JURG
IPC: A61B17/30
Filed: 2003-04-10
Abstract: A device for detachably connecting an ophthalmological functional unit (50) to a housing (10), preferably a housing embodied as a handle. The device comprises a connecting element (25) which is arranged on the housing and comprises moulded cylindrical connection pieces (30) for receiving the functional unit provided with a tool (80). The housing comprising the individual components forms a first modular unit and the functional unit comprising the tool forms a second modular unit. The two modular units are interconnected in a positively locking manner by means of correspondingly embodied means, and a rod (12) which is displaceably mounted in the first modular unit is actively connected to a sliding pin (60) mounted in the second modular unit, for the actuation of the tool.
Patent NZ-533541-A (NZ)
Title: Continuous process for production of oil seed protein isolate as opposed to a batch process
Inventor: BARKER LARRY D
IPC: A23J1/14
Filed: 2002-11-20
Abstract: A process for isolating protein isolates from oil seed meal on a continuous basis rather than by a batch procedure is described. When the extraction step is carried out in a continuous manner then the initial protein extraction step can be significantly reduced in time for the same or a higher level of protein extraction and significantly higher temperatures can be used. There is less chance of contamination therefore higher product quality is produced. The process can also be carried out on more compact equipment.
Patent NZ-534430-A (NZ)
Title: Production of delta 9 tetrahydrocannabinol from plant material
Inventor: GOODWIN NEIL JOHN
IPC: C07D311/80
Filed: 2003-02-03
Abstract: Disclosed herein is a method for the production of delta9 tetrahydrocannabinol (THC), which comprises extracting delta9 THC and delta9 THC carboxylic acid from plant material using a first solvent, extracting the acid using a second solvent at a pH of from 12.7 to 13.2, wherein the solvent preferentially dissolves the acid compared to delta9 THC, and optionally converting the delta9 THC acid into a derivative and extracting the derivative into a third solvent. Delta9 tetrahydrocannabinol (THC) acid is obtained from plant material and extracted into an aqueous solvent under conditions of pH control. the acid is converted to a salt and the salt extracted into a polar solvent, yielding acid of high purity. The delta9 THC acid is then converted to delta9 THC which is further purified and combined with a carrier for pharmaceutical use.